跳至主要内容
临床试验/TCTR20231005003
TCTR20231005003已完成2 期

Effect of Lidocaine Gel for Pain Relief during Endometrial Sampling in Postmenopausal bleeding: Randomized Controlled Trial

/A0 个研究点目标入组 72 人开始时间: 2023年10月5日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
72

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
N/A (No limit) 至 N/A (No limit)(—)
性别
Female

入选标准

  • women who were diagnosed with post menopausal bleeding and were literate, mature, and stable enough to do the visual analog score (VAS).

排除标准

  • 1.allergy to lidocaine jelly
  • 2.unstable vital signs for example systolic blood pressure (SBP) lower than 90 mmHg., diastolic blood pressure (SBP) lower than 60 mmHg., pulse rate more than 120 bpm.,
  • 3.patient unconsciousness or unable to answer the question and pain score.

研究者

发起方
/A

相似试验